348 related articles for article (PubMed ID: 9377859)
21. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension.
Falkner B; Canessa M; Anzalone D
Am J Hypertens; 1995 May; 8(5 Pt 1):454-60. PubMed ID: 7662220
[TBL] [Abstract][Full Text] [Related]
22. Association of increased erythrocyte Na+/H+ exchanger with renal Na+ retention in patients with essential hypertension.
Díez J; Alonso A; Garciandía A; López R; Gómez-Alamillo C; Arrázola A; Fortuño A
Am J Hypertens; 1995 Feb; 8(2):124-32. PubMed ID: 7755940
[TBL] [Abstract][Full Text] [Related]
23. Methodological assessment of assays for intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of man.
Lijnen P; Groeseneken D; Laermans M; Lommelen G; Piccart Y; Amery A
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):293-301. PubMed ID: 6087051
[TBL] [Abstract][Full Text] [Related]
24. Altered erythrocyte cation transport related to hypertension or oral contraception.
Stokes GS; Monaghan JC; Middleton A; Gunn J; Marwood JF
Klin Wochenschr; 1985; 63 Suppl 3():42-4. PubMed ID: 3999641
[TBL] [Abstract][Full Text] [Related]
25. [Sodium transport in red blood cell membranes in essential arterial hypertension].
Giménez MI; Grunfeld B; Simsolo R; Mayorga M; Becú L
Medicina (B Aires); 1989; 49(6):589-94. PubMed ID: 2487432
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
Sechi LA
Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
[TBL] [Abstract][Full Text] [Related]
27. Changes in erythrocyte sodium and plasma lipids associated with physical training.
Hespel P; Lijnen P; Fagard R; M'Buyamba-Kabangu JR; Van Hoof R; Lissens W; Rosseneu M; Amery A
J Hypertens; 1988 Feb; 6(2):159-66. PubMed ID: 2450911
[TBL] [Abstract][Full Text] [Related]
28. Intracellular sodium and calcium during antihypertensive treatment.
Zidek W; Karoff C; Baumgart P; Losse H; Fehske KJ; Häcker W; Vetter H
Klin Wochenschr; 1985; 63 Suppl 3():147-9. PubMed ID: 2860268
[TBL] [Abstract][Full Text] [Related]
29. [Antihypertensive effects of captopril, hydrochlorothiazide, alone or in combination, with different categories of essential hypertensive patients].
Senn N; Ollivier JP; Abitbol JP; Garay R
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():155-8. PubMed ID: 3142400
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte Na+-K+ cotransport in elderly hypertensive subjects.
Stessman J; Mekler J; Ben-Ishay D
Isr J Med Sci; 1985 Mar; 21(3):314-6. PubMed ID: 3997493
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
[TBL] [Abstract][Full Text] [Related]
32. Kinetic study of the Ca2+ pump in erythrocytes from essential hypertensive patients.
de la Sierra A; Hannaert P; Ollivier JP; Senn N; Garay R
J Hypertens; 1990 Mar; 8(3):285-93. PubMed ID: 2159510
[TBL] [Abstract][Full Text] [Related]
33. The regulation of Na-K cotransport system and essential hypertension.
Canessa M; Brugnara C
Klin Wochenschr; 1985; 63 Suppl 3():52-4. PubMed ID: 3999644
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte sodium and potassium transport systems during longterm administration of the diuretic xipamide in men.
Lijnen P; Amery A
Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):587-94. PubMed ID: 2586204
[TBL] [Abstract][Full Text] [Related]
35. Catecholamine-stimulated potassium transport in erythrocytes from normal and obese subjects.
Mazza P; Salvadori A; Baudo S; Fanari P; Fontana M; Ruga S; Longhini E
Minerva Med; 1992 Oct; 83(10):615-9. PubMed ID: 1334239
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of the Na+-K+-cotransport system in the erythrocyte membrane of patients with hypertension and symptomatic (renal) hypertension].
Kavtaradze VG; Aleksidze NG; Kvirikadze NK; Nadiradze NI
Biull Eksp Biol Med; 1986 Nov; 102(11):542-3. PubMed ID: 2430641
[TBL] [Abstract][Full Text] [Related]
37. Intracellular calcium in hypertension: effect of treatment with beta-adrenoreceptor blockers.
Baumgart P; Zidek W; Schmidt W; Haecker W; Dorst KG; Vetter H
J Cardiovasc Pharmacol; 1986; 8(3):559-61. PubMed ID: 2425173
[TBL] [Abstract][Full Text] [Related]
38. Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension.
Millar JA; Bramley PM; Paulin JM; Simpson FO
J Hypertens Suppl; 1984 Dec; 2(3):S461-3. PubMed ID: 6599699
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
[TBL] [Abstract][Full Text] [Related]
40. The effect of dietary sodium restriction on leucocyte sodium transport in normotensive subjects and in patients with essential hypertension.
Poston L; Johnson VE; Gray HH; Hilton PJ; Markandu ND; MacGregor GA
Klin Wochenschr; 1985; 63 Suppl 3():136-8. PubMed ID: 3999631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
